Les Kaplan
Direttore/Membro del Consiglio presso NICOX SA
Patrimonio netto: 30 056 $ in data 31/05/2024
Profilo
Lester J.
Kaplan is currently a Director at Nicox Ophthalmics, Inc., an Independent Director at Nicox SA, a Director at Keck Graduate Institute of Applied Life Sciences, a Director at Foundation Fighting Blindness Clinical Research Institute, a Director at FFB Clinical Research Institute, and a Director at AiViva BioPharma, Inc. He previously served as the Chairman of Altheos, Inc., Director & President-Research & Development at Allergan, Inc., Independent Director at ACADIA Pharmaceuticals, Inc., and Director at Neurotech Pharmaceuticals, Inc. He also held positions as a Director at Acucela, Inc. and Medinox, Inc. Kaplan obtained his graduate and doctorate degrees from the University of California, Los Angeles, and his undergraduate degree from the University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NICOX SA
0.16% | 31/12/2023 | 82 034 ( 0.16% ) | 30 056 $ | 31/05/2024 |
Posizioni attive di Les Kaplan
| Società | Posizione | Inizio |
|---|---|---|
| NICOX SA | Direttore/Membro del Consiglio | 01/10/2014 |
Foundation Fighting Blindness Clinical Research Institute
 Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Direttore/Membro del Consiglio | - |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Direttore/Membro del Consiglio | 01/01/2014 |
| Keck Graduate Institute of Applied Life Sciences | Direttore/Membro del Consiglio | - |
| FFB Clinical Research Institute | Direttore/Membro del Consiglio | - |
Aiviva Biopharma, Inc.
 Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Direttore/Membro del Consiglio | 18/09/2023 |
Precedenti posizioni note di Les Kaplan
| Società | Posizione | Fine |
|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 02/11/2015 |
Altheos, Inc.
 Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Presidente | 18/11/2013 |
| ALLERGAN, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2004 |
| ░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Les Kaplan
| University of California, Los Angeles | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| NICOX SA | Health Technology |
| Aziende private | 9 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
Neurotech Pharmaceuticals, Inc. (United States)
 Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Health Technology |
Acucela, Inc.
 Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Medinox, Inc.
 Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA. | Health Technology |
Foundation Fighting Blindness Clinical Research Institute
Foundation Fighting Blindness Clinical Research Institute Financial ConglomeratesFinance Foundation Fighting Blindness Clinical Research Institute provides investment services. The company is headquartered in Columbia, MD. | Finance |
Altheos, Inc.
Altheos, Inc. Pharmaceuticals: MajorHealth Technology Altheos, Inc. is an early stage biopharmaceutical company based in the San Francisco Bay area focused on development of highly promising near-clinical and clinical stage novel small molecule drugs. Altheos, Inc. was founded by two seasoned pharmaceutical executives, Dr. Henry H. Hsu and Dr. M. (Ken) Kengatharan who have extensive experience in rapid capital efficient drug development as well as financing and growth of early stage biopharmaceutical companies. | Health Technology |
| FFB Clinical Research Institute | |
Aiviva Biopharma, Inc.
Aiviva Biopharma, Inc. Pharmaceuticals: MajorHealth Technology AiViva BioPharma, Inc. is a clinical stage biotech company based in Costa Mesa, CA. AiViva is developing new therapeutics using innovative approaches, with proprietary technologies, including Jel™, to address high unmet medical needs through focal therapies that target diseases of neovascularization, abnormal cell proliferation, and fibrosis. The private company's core competencies include the development of novel drugs in specialty therapeutic areas of dermatology, ophthalmology, urology, and oncology. An estimated 100 million people in the developed world form scars following surgery. The company was founded in 2015 by Diane Tang-Liu, who has been the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Les Kaplan
